A61K 9/5169
Proteins
Official title: {Proteins, e.g. albumin, gelatin}
A61K9/5169 (Proteins) appears on 447 US grants and 876 published applications in this corpus.
Search patents in A61K- Granted patents
- 447
- Published applications
- 876
- Assignees
- 441
- Inventors
- 1,864
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 3 | 0 |
| 1999 | 10 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 1 |
| 2002 | 1 | 7 |
| 2003 | 5 | 10 |
| 2004 | 3 | 4 |
| 2005 | 1 | 4 |
| 2006 | 2 | 13 |
| 2007 | 0 | 20 |
| 2008 | 2 | 14 |
| 2009 | 4 | 24 |
| 2010 | 5 | 28 |
| 2011 | 7 | 20 |
| 2012 | 11 | 24 |
| 2013 | 10 | 31 |
| 2014 | 24 | 41 |
| 2015 | 18 | 43 |
| 2016 | 35 | 53 |
| 2017 | 26 | 75 |
| 2018 | 22 | 45 |
| 2019 | 46 | 45 |
| 2020 | 28 | 51 |
| 2021 | 22 | 59 |
| 2022 | 32 | 44 |
| 2023 | 25 | 65 |
| 2024 | 27 | 55 |
| 2025 | 31 | 58 |
| 2026 | 14 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treating vasculature related diseases or disorders using nanoparticles29 Sep 2026US 12,746,212 B2The Regents of the University of California
- Coronavirus and influenza compositions and methods for using them25 Aug 2026US 12,714,744 B2
- Radiopaque nanoparticles for medical imaging7 Jul 2026US 12,673,121 B2Translational and Fundamental Technologies Institute LLC
- Lymphoma cell-specific drug delivery system for prevention or treatment of lymphoma and method for preparing same9 Jun 2026US 12,648,910 B2Industry-Academic Cooperation Foundation, Yonsei University
- Scaffold proteins and therapeutic nanoconjugates based on nidogen9 Jun 2026US 12,649,776 B2Consorcio Centro De InvestigacióN BioméDica En Red
- Influenza ehead immunogens1 Oct 2026US 2026/0295029 A1The Scripps Research Institute
- Coronavirus s2 immunogens1 Oct 2026US 2026/0295034 A1The Scripps Research Institute
- A compound for preparing lipid nanoparticles encapsulating an agent, nanoparticle composition comprising said compound and related methods thereof24 Sep 2026US 2026/0283972 A1Agency for Science, Technology and Research
- Near-infrared aggregation-induced emission organic photothermal molecule and preparation method thereof and application27 Aug 2026US 2026/0248915 A1The Chinese University of Hong Kong, Shenzhen
- Recombinant hiv env polypeptides and their use27 Aug 2026US 2026/0250331 A1International AIDS Vaccine Initiative
Most cited
By later US patents
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Particle-containing complex porous materials721US 8,268,344 B2The Regents of the University of Michigan · 2012
- Anti-angiogenic compositions and methods of use413US 5,886,026 AAngiotech Pharmaceuticals, Inc. · 1999
- Composition useful for in vivo delivery of biologics and methods employing same369US 5,498,421 AVivorx Pharmaceuticals, Inc. · 1996
- Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor289US 5,439,686 AVivorx Pharmaceuticals, Inc. · 1995